Browsing by Author "Castro, Rui E."

Now showing items 1-4 of 4

    • Thumbnail

      A Novel Serum Metabolomic Profile for the Differential Diagnosis of Distal Cholangiocarcinoma and Pancreatic Ductal Adenocarcinoma 

      Macias, Rocio I. R.; Muñoz Bellvís, Luis; Sánchez Martín, Anabel; Arretxe Oliden, Enara; Martínez Arranz, Ibon; Lapitz Damborenea, Ainhoa; Gutiérrez, M. Laura; La Casta, Adelaida; Alonso, Cristina; González, Luis M.; Ávila, Matías A. ORCID; Martinez-Chantar, Maria L.; Castro, Rui E.; Bujanda Fernández de Pierola, Luis ORCID; Bañales Asurmendi, Jesús María ORCID; Marin, José J. G. (MDPI, 2020-05-31)
      The diagnosis of adenocarcinomas located in the pancreas head, i.e., distal cholangiocarcinoma (dCCA) and pancreatic ductal adenocarcinoma (PDAC), constitutes a clinical challenge because they share many symptoms, are not ...
    • Thumbnail

      Adiponectin, leptin, and IGF-1 are useful diagnostic and stratification biomarkers of NAFLD 

      Marques, Vanda; Afonso, Marta Bento; Bierig, Nina; Duarte-Ramos, Filipa; Santos Laso, Álvaro; Jiménez Agüero, Raúl; Eizaguirre Letamendia, Emma; Bujanda Fernández de Pierola, Luis ORCID; Pareja Megía, María J.; Luís, Rita; Costa, Adília; Machado, Mariana Verdelho; Alonso, Cristina; Arretxe Oliden, Enara; Alustiza Echeberria, José María; Krawczyk, Marcin; Lammert, Frank; Tiniakos, Dina G.; Flehmig, Bertram; Cortez-Pinto, Helena; Bañales Asurmendi, Jesús María ORCID; Castro, Rui E.; Normann, Andrea; Rodrigues, Cecilia M. P. (Frontiers Media, 2021-06-23)
      [EN] Background: Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease where liver biopsy remains the gold standard for diagnosis. Here we aimed to evaluate the role of circulating adiponectin, ...
    • Thumbnail

      miR-873-5p targets mitochondrial GNMT-Complex II interface contributing to non-alcoholic fatty liver disease 

      Fernández Tussy, Pablo; Fernández Ramos, David; Lopitz Otsoa, Fernando; Simon, Jorge; Barbier Torres, Lucía; Gómez Santos, Beatriz; Nuñez García, Maitane; Azkargorta, Mikel; Serrano Maciá, Marina; Gutiérrez de Juan, Virginia; Serrano Maciá, Marina; Rodríguez Agudo, Rubén; Iruzubieta, Paula; Anguita Castillo, Juan de Dios; Castro, Rui E.; Champagne, Devin; Rincon, Mercedes; Elortza, Felix; Arslanow, Anita; Krawczyk, Marcin; Lammert, Frank; Kirchmeyer, Melanie; Behrmann, Iris; Crespo, Javier; Lu, Shelly C.; Mato, José M.; Varela Rey, Marta; Aspichueta Celaá, Patricia; Delgado, Teresa C.; Martínez Chantar, María Luz ORCID (Elsevier, 2019-08-16)
      Objective: Non-alcoholic fatly liver disease (NAFLD) is a complex pathology in which several dysfunctions, including alterations in metabolic pathways, mitochondrial functionality and unbalanced lipid import/export, lead ...
    • Thumbnail

      RIPK3 acts as a lipid metabolism regulator contributing to inflammation and carcinogenesis in non-alcoholic fatty liver disease 

      Afonso, Marta Bento; Rodrigues, Pedro M.; Mateus Pinheiro, Miguel; Simao, André L.; Gaspar, María M.; Majdi, Amine; Arretxe Oliden, Enara; Alonso, Cristina; Santos Laso, Álvaro; Jiménez Agüero, Raúl; Eizaguirre Letamendia, Emma; Bujanda Fernández de Pierola, Luis ORCID; Pareja Megía, María J.; Bañales Asurmendi, Jesús María ORCID; ratziu, Vlad; Gautheron, Jeremie; Castro, Rui E.; Rodrigues, Cecilia M. P. (BMJ, 2021-12)
      [EN]Objective Receptor-interacting protein kinase 3 (RIPK3) is a key player in necroptosis execution and an emerging metabolic regulator, whose contribution to non-alcoholic fatty liver disease (NAFLD) is controversial. ...